Pediatric Renal Transplant Program

MANITOBA PEDIATRIC RENAL TRANSPLANT PROGRAM Rm FE009 840 Sherbrook Street Winnipeg, MB R3A 1S1 Phone (204) 787-4947 Office Hours: M-F 9 am-4 pm
Manitoba Pediatric Renal Transplant Program

Collaborative Family-Centered Care

The program takes a holistic approach to pediatric patients with end-stage renal disease, with an emphasis on family-centered care. Comprehensive pre- and post-transplant care is provided by a team of experienced specialists.

Values
Excellence
Integrity
Accountability
Respect

Care Team:

Medical Director	Dr. Patricia Birk, MD, FRCP(C)	Transplant Physician
Section Head (Pediatric Nephrology)	Dr. Tom Blydt-Hansen, MD, FRCP(C), FAAP	Transplant Physician
	Dr. Aviva Goldberg, MD, FRCP(C)	Transplant Physician, Bioethicist
	Dr. Kristen Pederson, MD, FRCP(C)	Dialysis Physician
	Dr.Joshua Koulack, MD, FRCP(C)	Transplant Surgeon
	Dr. Karen Psooy, MD, FRCS(C)	Urologist
	Dr. Nafisa Dharamsi, MD, FRCS(C)	Urologist
	Jocelyn Arpin, RN, BN	Transplant Nurse Clinician
	Sandy Neustaedter, RN	Dialysis Nurse Clinician
	Julie Strong, RN, BN	Pediatric Renal Transplant Coordinator (recipient)
	Josh Krongold	Social Worker
	Lisa Wilson	Dietician
	Dr. E. Sigurdson	Renal-Psychiatry Team
	Julie Pannell, RPN, RN	Renal-Psychiatry Team
	Melodie McCormick	Administration and Support Staff
	Gail Martin	Administration and Support Staff
	Jody Sawatzky	Adult Trasnplant Coordinator (Donor)

From Bench to Bedside:

The Manitoba Pediatric Kidney Transplant Program serves the provinces of Manitoba, Saskatchewan, Northwestern Ontario and Nunavit. Our program is recognized both nationally and internationally for its innovative clinical research. Cutting-edge research sets the standard for advances in the clinical care of transplanted children. Our unique innovations include:

1.
Pediatric Protocol Biopsy and Follow-Up Biopsy Programs for the early detection of subclinical (aka “silent”) rejection.

2.
Quantitative image analysis to monitor the progression of chronic allograft nephropathy (CAN, aka “scarring”), the leading cause of long-term graft loss in children.

3.
Noninvasive biomarkers of rejection using urine nuclear magnetic resonance (NMR).

4.
Clinical trials aimed at the modulation of CAN.

Links:

Canadian Society of Transplantation (CST)

American Society of Transplantation (AST)

International Pediatric Transplantation Association (IPTA)

Children’s Hospital of Winnipeg

Manitoba Institute of Child Health (MICH)